ep-2101
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2003 (NCT00054899)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ep2101
- ep-2101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00104780 | Phase 2 | Dec 1, 2004 | Epimmune |
| NCT00054912 | Phase 1 | Feb 1, 2003 | Epimmune |
| NCT00054899 | Phase 1 | Jan 1, 2003 | Epimmune |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Epimmune | For profit | 3 | 3 | 2 | 2003 |
1 organizations
Page 1 / 1